GAVISCON (GlaxoSmithKline Consumer Healthcare Holdings (US) LLC)
Welcome to the PulseAid listing for the GAVISCON drug offered from GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| NON-PROPRIETARY NAME: | aluminum hydroxide and magnesium carbonate |
| SUBSTANCE NAME: | ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | LIQUID |
| MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
| START MARKETING DATE: | 2014-08-01 |
| END MARKETING DATE: | 0000-00-00 |
GAVISCON HUMAN OTC DRUG Details:
| Item Description | GAVISCON from GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| LABELER NAME: | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 254; 237.5(mg/5mL; mg/5mL) |
| START MARKETING DATE: | 2014-08-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0135-0574_ede4661a-768d-4b5c-9eab-7ccfaea14b15 |
| PRODUCT NDC: | 0135-0574 |
| APPLICATION NUMBER: | part331 |
Other ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE Pharmaceutical Manufacturers / Labelers:
